In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

In conclusion, I see 2025 as a year in which the patient will still be centre-stage. But, in order for that to happen ...

According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated Disclosure UK system operated by the Association of the British ...